How to Buy Sensus Healthcare Stock
Sensus Healthcare Inc
Sensus Healthcare, Inc. , a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide.
Sensus Healthcare stock last closed at $4.59, down 2.75% from the previous day, and has increased 41.23% in one year. It has overperformed other stocks in the Medical Devices industry by 0.59 percentage points. Sensus Healthcare stock is currently +45.25% from its 52-week low of $3.16, and -50.8% from its 52-week high of $9.33.
There are currently 16.5M shares of SRTS outstanding. The market cap of SRTS is $75.71M. In the past 24 hours, 86,663 SRTS shares were traded.
How to Buy Sensus Healthcare Stock
Wondering how to invest in Sensus Healthcare stock? Here's how.
- Decide where to buy Sensus Healthcare stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you figure out where to buy Sensus Healthcare stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Put funds into your investment account: Choose your method of payment and add your information.
- Analyze Sensus Healthcare stock: The Sensus Healthcare ticker symbol is SRTS. Is Sensus Healthcare stock a good investment? Should you buy shares of SRTS? How do SRTS's underlying business fundamentals look? Do top analysts think Sensus Healthcare is a good buy? Why has SRTS's stock price moved recently? (Hint: Our stock research tools can help you evaluate if SRTS is a good stock to buy).
- Make your SRTS buy order: Decide if you will purchase SRTS shares at the current market price or use a limit order to purchase SRTS stock at a given price.
- Keep an eye on your SRTS position: Create a watchlist to keep tabs on your position in Sensus Healthcare shares.
Step 1: Decide where to buy Sensus Healthcare stock
You need an online brokerage account in order to access the NASDAQ market and buy SRTS shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global markets: From Technology to Financial Services, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've selected your brokerage, you'll need to fill out some personal info so you can buy SRTS stock today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to open a new trading account.
- Send your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've created your account on the best free stock trading app, you can securely and quickly fund your account:
Check out this video walkthrough if you need help depositing funds into your new brokerage account.
Step 4: Analyze Sensus Healthcare stock
Once you have decided on the best place to buy Sensus Healthcare stock, it's very important to analyze their stock before you invest, so you can understand the risk as well as the opportunity.
Sensus Healthcare quick stats
Fundamentals of SRTS
WallStreetZen was created to help everyday investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on SRTS's stock page.
What is the fair value of SRTS stock?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge SRTS's true value.
Using relative valuations ratios:
- SRTS may be undervalued based on its P/E ratio of 11.2x, relative to Medical Devices industry P/E ratio of 41.14x
- SRTS could be undervalued based on its P/B ratio of 1.36x, relative to Medical Devices industry P/B ratio of 3.8x
You can access more valuation research on SRTS's stock here.
SRTS Financial Summary
Pros:
- SRTS has cash burn of 1107000. It has sufficient cash and short-term investments to cover this for at least one year.
- SRTS profit margin has gone up from 2% to 15.9% in the past year.
- There are more short-term assets than short-term liabilities on the SRTS balance sheet.
- There are more short-term assets than long-term liabilities on the SRTS balance sheet.
- SRTS has $22.06M in cash and short term investments. This is enough to cover its annual cash burn of $1.11M.
- SRTS has a low debt to equity ratio of 0.11.
- Total SRTS debt is lower than 5 years ago, relative to shareholder equity.
Do Wall Street analysts think it's a good time to buy SRTS stock
Out of 3 Wall Street analysts who monitor SRTS, the consensus analyst rating on SRTS is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Sensus Healthcare stock forecast page.
SRTS Momentum
SRTS Performance Metrics
Last year, SRTS earnings were $6.65M. In the last 3 year, SRTS's earnings have increased by 86.18% per year. This was faster than the Medical Devices industry average of 10.26%.
Last year, SRTS revenue was $41.81M. In the last 5 year, SRTS's revenue has increased by 8.93% per year. This was slower than the Medical Devices industry average of 9.92%.
Dive into SRTS's earnings and revenue performance here.
Are SRTS executives and large shareholders buying or selling the stock?
Over the past 12 months, executives and large shareholders at SRTS have sold more shares than they have bought.
Javier Rampolla, CHIEF FINANCIAL OFFICER of SRTS, was the latest SRTS insider to buy. They bought $2,980.95 worth of SRTS stock on Feb 10, 2025.
Dig into more about who owns SRTS shares here.
Does SRTS stock generate passive income?
No, Sensus Healthcare doesn't provide an income stream by paying out dividends.
What others are saying about SRTS
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your SRTS buy order
You have two main order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are mostly sufficient. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a specific price limit, use a limit order.
Click the Open Trade button and your broker will execute your order.
If you need additional help buying stocks on eToro, click the helpful video below:
Step 6: Keep an eye on your SRTS position
Now that you own some SRTS stock, you'll want to stay up-to-date on your stock purchase.
Make a watchlist to monitor your SRTS stock.
SRTS Feed
How to Buy Stock in Sensus Healthcare
To reiterate, here are the 6 steps for buying Sensus Healthcare stock:
- Decide where to buy Sensus Healthcare stock
- Create your brokerage account
- Put funds into your investment account
- Analyze Sensus Healthcare stock
- Make your SRTS buy order
- Keep an eye on your SRTS position
If you are looking for a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest scoop on your investment in Sensus Healthcare, hit the button below to create your watchlist.
Trending Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.